ARTBIO AS
Operating
Utvikle markedsføre og selge medisinske produkter og utstyr samt det
som står i forbindelse med dette.
Forskning og utvikling av produkter til kreftbehandling etc
Organization
- CEO
- GF
- Chairman of the board
- CJ
- Years since formation
- 8 years
- since Apr 19, 2018
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 20
Ownership
- Number of shares and share classes
- 114,300
- 1 share class
- Total number of shareholders
- 1
- person
Financials
- Total operating income 2025
- 117,766,161
- NOK
- Annual total result 2025
- 11,558,414
- NOK
Last update: Oct 13, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
GF | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
CJ | Chairman | - |
GF | Board Member | - |
Last update: Oct 7, 2026
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 114,300 | 100 % |
Last update: Sep 25, 2026
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 117,766,161 | 74,292,646 | 60,439,239 | 25,797,042 | 1,910,083 |
Annual Total Result | 11,558,414 | 8,213,852 | 11,754,622 | -14,630,180 | -6,594,836 |
Total assets | 0 | 53,898,489 | 28,963,935 | 21,427,593 | 24,253,625 |
Total liabilities | 0 | 30,861,321 | 11,764,453 | 15,789,211 | 3,985,062 |
Total equity | 0 | 23,037,168 | 17,199,482 | 5,638,382 | 20,268,563 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 117,766,161 | 74,292,646 | 60,439,239 | 25,797,042 | 1,910,083 |
Total operating costs | 104,558,435 | 65,958,349 | 50,413,100 | 40,470,942 | 8,492,005 |
Operating result | 13,207,726 | 8,334,297 | 10,026,139 | -14,673,901 | -6,581,922 |
Financial income/costs | -1,649,312 | -120,444 | 1,728,483 | 43,720 | -12,914 |
Profit before tax | 11,558,414 | 8,213,852 | 11,754,622 | -14,630,180 | -6,594,836 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 | 0 |
Annual Total Result | 11,558,414 | 8,213,852 | 11,754,622 | -14,630,180 | -6,594,836 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 0 | 14,609,552 | 750,897 | 193,522 | 0 |
Total current assets | 0 | 39,288,937 | 28,213,038 | 21,234,071 | 24,253,625 |
Total assets | 0 | 53,898,489 | 28,963,935 | 21,427,593 | 24,253,625 |
Short term debt | 0 | 30,861,321 | 11,764,453 | 15,789,211 | 3,985,062 |
Long term debt | 0 | 0 | 0 | 0 | 0 |
Total liabilities | 0 | 30,861,321 | 11,764,453 | 15,789,211 | 3,985,062 |
Contributed capital | 0 | 23,037,168 | 17,199,482 | 32,363,975 | 32,363,975 |
Retained earnings | 0 | 0 | 0 | -26,725,593 | -12,095,412 |
Total equity | 0 | 23,037,168 | 17,199,482 | 5,638,382 | 20,268,563 |
Total equity and liabilities | 0 | 53,898,489 | 28,963,935 | 21,427,593 | 24,253,625 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification